Premium
Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
Author(s) -
Smits M. M.,
Tonneijck L.,
Muskiet M. H. A.,
Diamant M.,
Kramer M. H. H.,
Cahen D. L.,
Raalte D. H.
Publication year - 2017
Publication title -
diabetic medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 145
eISSN - 1464-5491
pISSN - 0742-3071
DOI - 10.1111/dme.13160
Subject(s) - exenatide , endocrinology , medicine , glucagon like peptide 1 receptor , diabetes mellitus , agonist , incretin , type 2 diabetes , type 2 diabetes mellitus , amylase , receptor , enzyme , chemistry , biochemistry
C. S. Hansen, J. Fleischer, D.Vistisen, M. Ridderstr ale, J. S. Jensen and M. E. Jørgensen Department of Clinical Epidemiology, Steno Diabetes Center A/S, Gentofte, Medical Research Laboratories, Clinical Institute of Medicine, Aarhus University, Aarhus, Steno Diabetes Center A/S, Gentofte, Department of Cardiology, Gentofte Hospital, Gentofte and National Institute of Public Health, Southern Denmark University, Odense, Denmark